BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 677-680

  Nguyen, L P ^a   Emley, A ^a   Wajapeyee, N ^b   Green, M R ^b   Mahalingam, M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Atypical genital naevi; BRAF V600E; IGFBP7

Indexed keywords

B RAF KINASE; GENOMIC DNA; MITOGEN ACTIVATED PROTEIN KINASE; BRAF PROTEIN, HUMAN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; SOMATOMEDIN BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; ATYPICAL GENITAL NEVUS; BRAF GENE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IGFBP7 GENE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; GENETICS; MIDDLE AGED; MUTATION; YOUNG ADULT;

ADOLESCENT; ADULT; DYSPLASTIC NEVUS SYNDROME; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 76949091228     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09558.x     Document Type: Article

References (11)

1. Clark WH Jr., Hood AF, Tucker MA et al. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol 1998 29 : S1 24.
2. Gleason BC, Hirsch MS, Nucci MR et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008 32 : 51 7.
3. Massi G, LeBoit PE (eds). Nevi on Genital Skin. Darmstadt : SteinKopf Verlag, 2004.
4. Wajapeyee N, Serra RW, Zhu X et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008 132 : 363 374.
5. Ruan WJ, Lin J, Xu EP et al. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B 2006 7 : 929 932.
6. Kato MV. A secreted tumor-suppressor, mac25, with activin-binding activity. Mol Med 2000 6 : 126 135.
7. James MR, Roth RB, Shi MM et al. BRAF polymorphisms and risk of melanocytic neoplasia. J Invest Dermatol 2005 125 : 1252 1258.
8. Pollock PM, Harper UL, Hansen KS et al. High frequency of BRAF mutations in nevi. Nat Genet 2003 33 : 19 20.
9. Cohen Y, Rosenbaum E, Begum S et al. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 2004 10 : 3444 3447.
10. Ichii-Nakato N, Takata M, Takayanagi S et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 2006 126 : 2111 2118.
11. Vasko V, Hu S, Wu G et al. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes. J Clin Endocrinol Metab 2005 90 : 5265 5269.